Beyond medications: office-based procedures for benign prostatic obstruction

被引：0
作者：
Phuong U. Tran
Amanda S. J. Chung
机构：
[1] Bankstown-Lidcombe Hospital,Department of Urology, Royal North Shore Hospital
[2] The University of Sydney,Department of Urology
[3] Macquarie University Hospital,undefined
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive surgical procedures; Stents; Water;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1023 / 1027
页数：4
相关论文
共 50 条
  • [41] Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis
    Rachel Altman
    Roseanne Ferreira
    Camilo Barragan
    Naeem Bhojani
    Katherine Lajkosz
    Kevin C. Zorn
    Bilal Chughtai
    Ganesan Annamalai
    Dean S. Elterman
    [J]. BMC Urology, 24
  • [42] Negative effects on sexual function of medications for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
    Descazeaud, A.
    de La Taille, A.
    Giuliano, F.
    Desgrandchamps, F.
    Doridot, G.
    [J]. PROGRES EN UROLOGIE, 2015, 25 (03): : 115 - 127
  • [43] Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement
    Tammela, TLJ
    Schäfer, W
    Barrett, DM
    Abrams, P
    Hedlund, H
    Rollema, HJ
    Matos-Ferreira, A
    Nordling, J
    Bruskewitz, R
    Miller, P
    Kirby, R
    Andersen, JT
    Jacobsen, C
    Gormley, GJ
    Malice, MP
    Bach, MA
    [J]. NEUROUROLOGY AND URODYNAMICS, 1999, 18 (01) : 17 - 24
  • [44] Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride
    Wada, Naoki
    Matsumoto, Seiji
    Kita, Masafumi
    Hashizume, Kazumi
    Kakizaki, Hidehiro
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (12) : 1258 - 1262
  • [45] Hormonal manipulation of lower urinary tract symptoms secondary to benign prostatic obstruction
    Raja, Adita
    Hori, Satoshi
    Armitage, James N.
    [J]. INDIAN JOURNAL OF UROLOGY, 2014, 30 (02) : 189 - 193
  • [46] EFFECT OF NAFTOPIDIL ON URETHRAL OBSTRUCTION IN BENIGN PROSTATIC HYPERPLASIA - ASSESSMENT BY URODYNAMIC STUDIES
    YASUDA, K
    YAMANISHI, T
    TOJO, M
    NAGASHIMA, K
    AKIMOTO, S
    SHIMAZAKI, J
    [J]. PROSTATE, 1994, 25 (01) : 46 - 52
  • [47] Interactions between medications employed in treating benign prostatic hyperplasia and food - A short review
    Pasko, Pawel
    Rodacki, Tomasz
    Domagala-Rodacka, Renata
    Owczarek, Danuta
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 1141 - 1145
  • [48] State of the art on stress incontinence management after benign prostatic obstruction surgery
    Sabbagh, Paul
    Dupuis, Hugo
    Cornu, Jean-Nicolas
    [J]. CURRENT OPINION IN UROLOGY, 2021, 31 (05) : 473 - 478
  • [49] Evaluation of new treatments for benign prostatic obstruction: ICI-RS 2023
    Hashim, Hashim
    Tarcan, Tufan
    Acar, Omer
    Malde, Sachin
    Wein, Alan
    Abrams, Paul
    [J]. NEUROUROLOGY AND URODYNAMICS, 2024, 43 (06) : 1409 - 1419
  • [50] Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms
    Wang, Delin
    Huang, Honghong
    Law, Yan Mee
    Foo, Keong Tatt
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (02) : 60 - 65
12345